Smith Anglin Financial, LLC Baxter International Inc Transaction History

Smith Anglin Financial, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 10, 2023	SELL	$39.98 - $47.68 $28,265 - $33,709	-707 Reduced 11.67%	5,349 $243,000
Q1 2023 Apr 11, 2023	SELL	$37.58 - $52.57 $9,207 - $12,879	-245 Reduced 3.89%	6,056 $245,000
Q4 2022 Feb 14, 2023	SELL	$49.7 - $57.71 $2,236 - $2,596	-45 Reduced 0.71%	6,301 $321,000
Q3 2022 Oct 24, 2022	BUY	$53.86 - $66.8 $1,561 - $1,937	29 Added 0.46%	6,346 $342,000
Q2 2022 Jul 25, 2022	SELL	$63.83 - $80.0 $55,340 - $69,360	-867 Reduced 12.07%	6,317 $406,000
Q1 2022 May 16, 2022	SELL	$76.85 - $89.45 $67,474 - $78,537	-878 Reduced 10.89%	7,184 $557,000
Q4 2021 Jan 31, 2022	BUY	$74.57 - $87.19 $2,087 - $2,441	28 Added 0.35%	8,062 $692,000
Q3 2021 Oct 20, 2021	BUY	$73.77 - $83.61 $1,991 - $2,257	27 Added 0.34%	8,034 $646,000
Q2 2021 Aug 10, 2021	BUY	$80.5 - $88.01 $1,851 - $2,024	23 Added 0.29%	8,007 $645,000
Q1 2021 Jul 08, 2021	BUY	$76.38 - $86.03 $1,909 - $2,150	25 Added 0.31%	7,984 $673,000
Q4 2020 Jul 08, 2021	BUY	$75.39 - $82.36 $600,029 - $655,503	7,959 New	7,959 $639,000

998

450M

1.97M

3.04M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $17.5B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Smith Anglin Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Smith Anglin Financial, LLC with notifications on news.